Addiction Therapies
Total Trials
2
As Lead Sponsor
1
As Collaborator
Total Enrollment
48
NCT03203499
A Study to Evaluate the Safety of the Coadministration of ANS-6637 and Ethanol
Phase: Phase 1
Role: Lead Sponsor
Start: Feb 27, 2017
Completion: Nov 15, 2017
NCT04311294
Development of a Selective ALDH2 Inhibitor to Treat AUD
Phase: Phase 2
Role: Collaborator
Start: Apr 30, 2020
Completion: Mar 31, 2022
Loading map...